Severe iatrogenic hypoglycemia in type 2 diabetes mellitus

Philip E Cryer

doi:10.1038/ncpendmet0355 | Full Text | PDF (86K)

Rosiglitazone, but not ramipril, prevents onset of type 2 diabetes in high-risk patients

doi:10.1038/ncpendmet0357 | Full Text | PDF (58K)

Insulin-independence is rarely sustained after pancreatic islet transplantation

doi:10.1038/ncpendmet0358 | Full Text | PDF (58K)

New protocols for the management of hyperglycemia in hospitalized patients

doi:10.1038/ncpendmet0359 | Full Text | PDF (59K)

Dose escalation of pramlintide improves its tolerability and efficacy

doi:10.1038/ncpendmet0360 | Full Text | PDF (59K)

Are antihypertensive drugs associated with an increased risk of incident type 2 diabetes?

Pantelis A Sarafidis and George L Bakris

doi:10.1038/ncpendmet0315 | Full Text | PDF (90K)

Clinical and public health implications of glycemic relapse in type 2 diabetes

Patrick J O'Connor and JoAnn Sperl-Hillen

doi:10.1038/ncpendmet0354 | Full Text | PDF (89K)

How prevalent are diabetes-related complications in patients with youth-onset type 2 diabetes mellitus?

Jennifer Miller and Janet Silverstein

doi:10.1038/ncpendmet0356 | Full Text | PDF (87K)

The neuropathic diabetic foot

Haris M Rathur and Andrew JM Boulton

doi:10.1038/ncpendmet0347 | Full Text | PDF (390K)

The changing costs and benefits of screening for asymptomatic coronary heart disease in patients with diabetes

Martin K Rutter and Richard W Nesto

doi:10.1038/ncpendmet0352 | Full Text | PDF (270K)

Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes

Christian Rask-Madsen and George L King

doi:10.1038/ncpendmet0366 | Full Text | PDF (295K)

Mechanisms of Disease: advances in diagnosis and treatment of hyperinsulinism in neonates

Diva D De León and Charles A Stanley

doi:10.1038/ncpendmet0368 | Full Text | PDF (574K)